Skip to content
  • Tuesday, 16 June 2026
  • 8:56 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Simcere Pharmaceutical Group Partners with Stanford Medicine to Pioneer Novel Therapies for Idiopathic Pulmonary Fibrosis
Pharmaceutical R&D

Simcere Pharmaceutical Group Partners with Stanford Medicine to Pioneer Novel Therapies for Idiopathic Pulmonary Fibrosis

Teuku Ryan Jun 16, 2026 0

Simcere Pharmaceutical Group has forged a significant research collaboration with Stanford Medicine, aiming to unlock novel therapeutic avenues for idiopathic…

Read More
Osaka Metropolitan University Researchers Develop Self-Regulating Artificial Photosynthesis System to Produce Solar Fuel Without Battery StorageAntibiotic Residues Found in Piracicaba River and Local Fish, Raising Public Health ConcernsPioneering Digital Pathology Summit Explores AI, Data Integration, and Transformative Technologies for Modern LaboratoriesPeptides are unproven as health aids. FDA may unleash them anyway
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Ludwig Cancer Research Study Identifies Novel Synergistic Combination Therapy to Overcome Differentiation Block in Acute Myelogenous LeukemiaIn Focus Wrapped: Metabolite monitoring in cell cultureRubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense rednessExercise and Low-Dose Ibuprofen Show Promise in Mitigating Chemotherapy-Induced Cognitive Impairment
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Ludwig Cancer Research Study Identifies Novel Synergistic Combination Therapy to Overcome Differentiation Block in Acute Myelogenous Leukemia
Dwi Wanna Jun 16, 2026
Biotech & Genetic Research
In Focus Wrapped: Metabolite monitoring in cell culture
Jia Lissa Jun 16, 2026
Laboratory Automation & Robotics
Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
Lana Keisha Jun 16, 2026
Neuroscience & Brain Research
Exercise and Low-Dose Ibuprofen Show Promise in Mitigating Chemotherapy-Induced Cognitive Impairment
Rifan Muazin Jun 16, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ